Peter A. Drew

962 total citations
38 papers, 701 citations indexed

About

Peter A. Drew is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Peter A. Drew has authored 38 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Epidemiology. Recurrent topics in Peter A. Drew's work include Cervical Cancer and HPV Research (7 papers), Oral and Maxillofacial Pathology (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Peter A. Drew is often cited by papers focused on Cervical Cancer and HPV Research (7 papers), Oral and Maxillofacial Pathology (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Peter A. Drew collaborates with scholars based in United States, Chile and Saudi Arabia. Peter A. Drew's co-authors include William M. Murphy, Francisco Civantos, V. O. Speights, Jaime Furman, Gary Visner, Nancy S. Hardt, Jonathan I. Epstein, Mehsati Herawi, Chin‐Chen Pan and Barbara B. Bennett and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and The Journal of Urology.

In The Last Decade

Peter A. Drew

37 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter A. Drew United States 13 389 244 141 128 109 38 701
V Russack United States 12 187 0.5× 132 0.5× 146 1.0× 155 1.2× 77 0.7× 20 704
Seema Kaushal India 13 201 0.5× 81 0.3× 30 0.2× 79 0.6× 96 0.9× 86 483
Madhu Mati Goel India 13 190 0.5× 83 0.3× 22 0.2× 76 0.6× 90 0.8× 65 461
Jiangnan Xu China 17 168 0.4× 84 0.3× 31 0.2× 85 0.7× 219 2.0× 34 911
G. Klöppel Germany 10 236 0.6× 75 0.3× 67 0.5× 62 0.5× 83 0.8× 34 392
Aylin Gül Türkiye 12 159 0.4× 67 0.3× 18 0.1× 57 0.4× 60 0.6× 55 410
Toshitatsu Nogita Japan 14 75 0.2× 90 0.4× 44 0.3× 195 1.5× 201 1.8× 55 671
Hema Kini India 13 171 0.4× 68 0.3× 16 0.1× 95 0.7× 90 0.8× 82 419
Eleanor Mallon United Kingdom 14 176 0.5× 28 0.1× 54 0.4× 131 1.0× 133 1.2× 16 709
Teresa Russo Italy 15 65 0.2× 82 0.3× 28 0.2× 214 1.7× 175 1.6× 67 642

Countries citing papers authored by Peter A. Drew

Since Specialization
Citations

This map shows the geographic impact of Peter A. Drew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Drew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Drew more than expected).

Fields of papers citing papers by Peter A. Drew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Drew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Drew. The network helps show where Peter A. Drew may publish in the future.

Co-authorship network of co-authors of Peter A. Drew

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Drew. A scholar is included among the top collaborators of Peter A. Drew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Drew. Peter A. Drew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drew, Peter A., et al.. (2021). Primary cardiac low-grade neuroendocrine tumor: a case report and review of the literature. Cardiovascular Pathology. 52. 107317–107317. 2 indexed citations
2.
King, Robert B., Peter A. Drew, & Brian D. Stewart. (2021). Sclerosing Polycystic Adenoma: a Case Report and Review of Literature. SN Comprehensive Clinical Medicine. 3(6). 1463–1468. 1 indexed citations
3.
Fitzpatrick, Sarah, et al.. (2021). Secretory Carcinoma of the Oral Cavity: A Retrospective Case Series with Review of Literature. Head and Neck Pathology. 15(3). 893–904. 9 indexed citations
4.
Keeley, Ellen C., Ali Ataya, John W. Petersen, et al.. (2020). Breaking hearts and taking names: A case of sarcoidosis related effusive-constrictive pericarditis. Respiratory Medicine. 163. 105879–105879. 7 indexed citations
5.
Drew, Peter A., et al.. (2019). Cancer Genes Mutations in Benign Metastasizing Leiomyoma: A Case Report. Cureus. 11(7). e5154–e5154. 2 indexed citations
6.
Biswas, Abhishek, Marino E. Leon, Peter A. Drew, et al.. (2018). Clinical performance of endobronchial ultrasound‐guided transbronchial needle aspiration for assessing programmed death ligand‐1 expression in nonsmall cell lung cancer. Diagnostic Cytopathology. 46(5). 378–383. 35 indexed citations
7.
8.
Al‐Quran, Samer Z., et al.. (2010). Smoothelin immunohistochemistry is a useful adjunct for assessing muscularis propria invasion in bladder carcinoma. Histopathology. 56(7). 951–956. 19 indexed citations
9.
Herawi, Mehsati, Peter A. Drew, Chin‐Chen Pan, & Jonathan I. Epstein. (2010). Clear cell adenocarcinoma of the bladder and urethra: cases diffusely mimicking nephrogenic adenoma. Human Pathology. 41(4). 594–601. 58 indexed citations
10.
Stewart, Carol, Indraneel Bhattacharyya, Kathleen M. Berg, et al.. (2008). Labial salivary gland biopsies in Sjögren's syndrome: still the gold standard?. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 106(3). 392–402. 21 indexed citations
11.
Liu, Hanzhong, et al.. (2005). Pirfenidone Inhibits Lung Allograft Fibrosis through L-Arginine–Arginase Pathway. American Journal of Transplantation. 5(6). 1256–1263. 65 indexed citations
12.
Liu, Hanzhong, et al.. (2005). Pirfenidone inhibits inflammatory responses and ameliorates allograft injury in a rat lung transplant model. Journal of Thoracic and Cardiovascular Surgery. 130(3). 852–858. 36 indexed citations
13.
Malik, Shazli N., et al.. (1999). Do Qualifiers of ASCUS Distinguish Between Low- and High-Risk Patients?. Acta Cytologica. 43(3). 376–380. 41 indexed citations
14.
Bennett, Barbara B., et al.. (1998). Atypical Glandular Cells of Undetermined Significance and Other Glandular Cell Abnormalities in a High-Risk Population. Journal of Lower Genital Tract Disease. 2(3). 132–135. 8 indexed citations
15.
Bennett, Barbara B., et al.. (1998). Squamous Intraepithelial Lesions of the Cervix in a High-Risk Population. Journal of Lower Genital Tract Disease. 2(3). 136–140. 11 indexed citations
16.
Drew, Peter A., et al.. (1998). Pulmonary cryptococcosis and pituitary Cushing's disease. Diagnostic Cytopathology. 18(5). 365–367. 11 indexed citations
17.
Bennett, Barbara B., et al.. (1997). Atypical Squamous Cells of Undetermined Significance in a High-Risk Population. Journal of Lower Genital Tract Disease. 1(4). 210–213. 3 indexed citations
18.
Drew, Peter A., et al.. (1997). Can androgen deprivation with leuprolide be predicted from histology alone? If not, why not?. PubMed. 157(6). 2201–5. 6 indexed citations
19.
Drew, Peter A., William M. Murphy, Francisco Civantos, & V. O. Speights. (1996). The histogenesis of clear cell adenocarcinoma of the lower urinary tract: Case series and review of the literature. Human Pathology. 27(3). 248–252. 63 indexed citations
20.
Hendricks, James B., et al.. (1994). Ki-67 Expression in Vulvar Carcinoma. International Journal of Gynecological Pathology. 13(3). 205–210. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026